In neuroblastoma, the ErbB tyrosine kinases, such as EGFR and ERBB4, have been reported to promote cell growth and prevent apoptosis in preclinical models via the MAPK–ERK and PI3K–AKT49–51 pathways. The gene discussed is EGFR; the disease is neuroblastoma.